Literature DB >> 2058858

Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen.

R P Perrillo1, E M Brunt.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2058858     DOI： 10.7326/0003-4819-115-2-113

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  11 in total

Review 1.  A practical guide to the use of interferons in the management of hepatitis virus infections.

Authors:  G Saracco; M Rizzetto
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?

Authors:  Vincent S K Yip; Tan To Cheung; Ronnie T P Poon; Thomas Yau; James Fung; Wing Chiu Dai; Albert C Y Chan; Siu Ho Chok; See Ching Chan; Chung Mau Lo
Journal:  Transl Gastroenterol Hepatol       Date:  2016-06-14

Review 3.  Interferon in the management of chronic hepatitis B.

Authors:  R P Perrillo
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

Review 4.  Current management strategies for hepatitis B in the elderly.

Authors:  P Merle; C Trépo; F Zoulim
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.

Authors:  F ter Borg; F J ten Kate; H T Cuypers; A Leentvaar-Kuijpers; J Oosting; P M Wertheim-van Dillen; P Honkoop; M C Rasch; R A de Man; J van Hattum; R A Chamuleau; G N Tytgat; E A Jones
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

6.  Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus.

Authors:  Fernando Lopes Gonçales; Josiane Silveira Felix Pereira; Claudia Da Silva; Glaucimari Roberto Thomaz; Maria Helena Postal Pavan; Viviane Cristina Fais; Luis Alberto Magna; Neiva Sellan Lopes Gonçales
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

7.  A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.

Authors:  V Perez; J Findor; H Tanno; J Sordá
Journal:  Gut       Date:  1993       Impact factor: 23.059

8.  Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values.

Authors:  Shogo Okoshi; Masato Igarashi; Takeshi Suda; Hiroshi Iwamatsu; Kohji Watanabe; Kiyoshi Ishihara; Norio Ogata; Minoru Nomoto; Toru Takahashi; Takafumi Ichida; Hitoshi Asakura; Koei Nihei; Isao Kurosaki
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

9.  One year of Lamivudine therapy for portuguese patients with chronic hepatitis B.

Authors:  J Areias; F Calinas; A Porto; A Carvalho; D Freitas; G Macedo; R Noronha; J Cotter; A Meliço-Silvestre; R Peixe; J Pratas; D Barrote; R Teixeira; F Augusto; I Carrilho; F Campante; J Velosa; L Carvalho; M A Duarte; H Guerreiro; C Pires; A Silva; I Cotrim; F Guedes; L Tomé; M Marcelino; C Gonçalves; E Ferreira; L Matos; P Peixe; J Esteves; T Valente; C Simões; C Marinho; L Jasmins; M J Vieira; R Marinho; P Matos; J Estevens; J Carrasquinho; G Salcedo; P Parada; C Teixeira
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

10.  A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients.

Authors:  Jia-Jie Lu; En-Qiang Chen; Jia-Hong Yang; Tao-You Zhou; Li Liu; Hong Tang
Journal:  Virol J       Date:  2012-01-10       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.